MHLD Regional Coordinators, Susan O’Leary (Barnstable) and Valerie Rust (Suffolk), present:
Groundbreaking Innovative Treatments for Treatment-Resistant Suicidal Ideation
October 27, 1-3p (2 CLEs) via Zoom
This training provides MHLD attorneys with an overview of emerging, evidence-based treatments for individuals experiencing treatment-resistant suicidal ideation. Participants will explore how advances in psychiatric care including novel pharmacologic and neuromodulation therapies may affect legal decision-making in civil commitment, guardianship, and substituted judgment proceedings.
Learning Objectives:
Upon completion of this training, participants will be able to:
- Identify emerging evidence-based treatments for treatment-resistant suicidal ideation and understand their potential role in reducing suicide risk and improving patient outcomes.
- Evaluate the legal, ethical, and constitutional considerations associated with innovative psychiatric treatments in civil commitment, guardianship, and substituted judgment proceedings.
- Apply current clinical knowledge to advocate effectively in court, collaborate with mental health professionals, and make informed legal recommendations that balance patient autonomy, public safety, and access to appropriate treatment.
Please register in advance here. After registering, you will receive a link to join the training.